Current:Home > reviewsGolnesa "GG" Gharachedaghi Shares Why She Doesn't "Hide" Using Ozempic for Weight Loss -Global Finance Compass
Golnesa "GG" Gharachedaghi Shares Why She Doesn't "Hide" Using Ozempic for Weight Loss
TradeEdge View
Date:2025-04-10 21:35:30
Golnesa "GG" Gharachedaghi is getting candid on her health journey.
The Shahs of Sunset star recently shared why she chose to be open about using Ozempic, the Type 2 diabetes medication that some are using as a weight-loss drug.
"I don't see a reason to hide being on a weight loss [medication] or a cosmetic procedure," Golnesa told Entertainment Tonight May 18, "just talk about it because there's so many people out there who want to do the same thing or they want to learn about what you did."
She added, "Obviously, I didn't look like this two months ago. So, all of a sudden, to lose almost 30 pounds, I would be a liar to say I quit drinking alcohol and you know all of a sudden started working out like some people like to say."
Golnesa also noted that she still has an appetite, saying, "I'm actually a little hungry. Look I'm gonna go smoke a little pot and I'm gonna eat definitely."
Back in February, the 41-year-old posted a video to Instagram describing her experience with Semaglutide—the generic version of the weight-loss drug—for her followers.
"I am on the weight-loss shots, honey, OK," Golnesa said in the Feb. 28 video. "I'm just not going to lie about it because I always keep it real about what is fake."
She captioned the clip, "I'm not sure why so many people deny taking the shots. Y'all can judge in the comments section below, but for those interested in trying this, you should hit up my doctor @tabasum and get started."
However, Golnesa isn't the only celebrity in the Bravo-verse to speak about Ozempic, as four months earlier, The Real Housewives of Beverly Hills star Kyle Richards denied claims that she was also taking the drug.
The Halloween Ends actress responded to one user under a Jan. 5 Instagram picture of herself and her girlfriends—including former Real Housewife Teddi Mellencamp—after a workout, writing, "I am NOT on ozempic."
In a second comment, Kyle said, "Never have been."
Instead, the reality star credits a lean diet and intense workout routine for her body changes.
"Like I said, not Ozempic or that other one that starts with an ‘M,'" Kyle shared during an Amazon Live in January. "I changed my eating after we were in Europe for a month. We were in Europe for three weeks and then Australia for a week, and I had gained weight, and I was like, ‘Okay, that's it.' No sugar, no carbs, no alcohol."
When E! News previously reached out for comment, a rep for Novo Nordisk shared that Ozempic is "not approved for chronic weight management." The brand's statement said it's intended to treat type 2 diabetes, improve blood sugar and reduce the risk of major cardiovascular events for adults with the condition.
(E! and Bravo are both part of the NBCUniversal family.)
For the latest breaking news updates, click here to download the E! News AppveryGood! (22278)
Related
- The company planning a successor to Concorde makes its first supersonic test
- Scientists Say It’s ‘Fatally Foolish’ To Not Study Catastrophic Climate Outcomes
- Houston lesbian bar was denied insurance coverage for hosting drag shows, owner says
- Is AI a job-killer or an up-skiller?
- Meet the volunteers risking their lives to deliver Christmas gifts to children in Haiti
- Overwhelmed by Solar Projects, the Nation’s Largest Grid Operator Seeks a Two-Year Pause on Approvals
- In Climate-Driven Disasters, Older People and the Disabled Are Most at Risk. Now In-Home Caregivers Are Being Trained in How to Help Them
- Kate Middleton Turns Heads in Royal Blue at King Charles III's Scottish Coronation Ceremony
- From family road trips to travel woes: Americans are navigating skyrocketing holiday costs
- OceanGate Suspends All Explorations 2 Weeks After Titanic Submersible implosion
Ranking
- NFL Week 15 picks straight up and against spread: Bills, Lions put No. 1 seed hopes on line
- Biden says debt ceiling deal 'very close.' Here's why it remains elusive
- The U.S. is expanding CO2 pipelines. One poisoned town wants you to know its story
- Why the Luster on Once-Vaunted ‘Smart Cities’ Is Fading
- As Trump Enters Office, a Ripe Oil and Gas Target Appears: An Alabama National Forest
- Overwhelmed by Solar Projects, the Nation’s Largest Grid Operator Seeks a Two-Year Pause on Approvals
- Warming Trends: Heat Indexes Soar, a Beloved Walrus is Euthanized in Norway, and Buildings Designed To Go Net-Zero
- In Climate-Driven Disasters, Older People and the Disabled Are Most at Risk. Now In-Home Caregivers Are Being Trained in How to Help Them
Recommendation
EU countries double down on a halt to Syrian asylum claims but will not yet send people back
California Released a Bold Climate Plan, but Critics Say It Will Harm Vulnerable Communities and Undermine Its Goals
It’s Happened Before: Paleoclimate Study Shows Warming Oceans Could Lead to a Spike in Seabed Methane Emissions
Max streaming service says it will restore writer and director credits after outcry
Justice Department, Louisville reach deal after probe prompted by Breonna Taylor killing
Intel named most faith-friendly company
3 ways to protect your money if the U.S. defaults on its debt
MTV News shut down as Paramount Global cuts 25% of its staff